FERRING PHARMACEUTICALS LTD
Founded in 1950 by Dr Frederik
Paulsen, Ferring Pharmaceuticals is focused on the research
and commercial development of peptides - natural
compounds that play a role in virtually all of the body's
systems. Ferring produces pharmaceuticals in specific
therapeutic areas to help clinicians treat patients on the
body's own terms.
As a dedicated, research-driven biopharmaceutical
company, Ferring identifies, develops and markets innovative
products in the fields of fertility, obstetrics, endocrinology,
urology and gastroenterology.
Ferring continues to invest in R&D to enable the
introduction of new and enhanced medicines. At present,
there are a number of major projects in the Ferring R&D
pipeline, which complement the existing portfolio and offer
innovative development of current brands. They also fit
neatly into the core expertise areas of peptide chemistry,
pharmacology and drug delivery systems.
Ferring's developmental activities are on a global scale
and are conducted in collaboration with leading academic
centres and teaching hospitals worldwide. Co-ordination of
development is maintained from the International
PharmaScience Center in Copenhagen, Denmark. The
accumulated knowledge and experience of Ferring are
paving the way for novel compounds that will become
tomorrow's pharmaceuticals.
Ferring Pharmaceuticals Ltd, The Courtyard, Waterside Drive, Langley SL3 6EZ, UK
Tel: 01753-214800
http://www.ferring.co.uk